Trial Profile
An open label, multi-centre, prospective study to demonstrate safety and efficacy of once daily Advagraf in patients undergoing kidney or liver transplantation in India.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Immunosuppressants
- Indications Liver transplant rejection; Renal transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Astellas Pharma
- 05 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 22 Aug 2012 Planned End Date 31 Jan 2013 added as reported by Clinical Trial Registry - India record.
- 09 May 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trial Registry - India record.